Kelvin Baggett
Managing Director, Head of Patient Impact and Chair of the EMPIRIC Institute, Patient Square Capital
Kelvin A. Baggett, M.D. is Managing Director, Head of Patient Impact and Chair of EMPIRIC Institute at Patient Square Capital. In his leadership role with Patient Square’s EMPIRIC Institute, Dr. Baggett utilizes his extensive health care experience to measure and drive improvements in quality, care delivery, health outcomes, and patient impact across Patient Square’s investments. Prior to joining Patient Square, Dr. Baggett served as Executive Vice President & Chief Impact Officer at McKesson, a Fortune 10 company. As a member of McKesson’s Executive Operating Team, he was responsible for global strategic initiatives and played a pivotal role in shaping McKesson’s purpose of “Advancing Health Outcomes for All.”Before McKesson, Kelvin served as the Chief Operating Officer for Health Care Navigator, the Senior Vice President & Chief Clinical Officer at Tenet Healthcare Corporation, and prior to that as the Chief Operating Officer, Clinical Services Group for HCA Healthcare. During the COVID-19 pandemic, Kelvin served as a civic volunteer as the City of Dallas’ COVID-19 Health and Healthcare Access Czar. Dr. Baggett completed his Internal Medicine training at Yale University, advanced training as a Robert Wood Johnson Clinical Scholar at Johns Hopkins University and as a fellow at Duke University. He earned his B.S. in Biology from the University of North Carolina at Chapel Hill, a Doctor of Medicine Degree from East Carolina University, a Master of Public Health Degree from Johns Hopkins University, and a Master of Business Administration from Duke University.
